Pulse Biosciences (Nasdaq:PLSE) today announced the first U.S. procedure with its CellFX nsPFA percutaneous electrode system.

Outset Medical (Nasdaq: OM) shares fell this morning on first-quarter misses and restructuring resulting in headcount ...

Neuralink’s brain-computer interface Link has encountered its first problem in its first human patient. The company reported ...

The FDA shared "continued safety and quality concerns" about Getinge/Maquet cardiovascular recalls as MDRs continue despite ...

t:slim X2 Insulin Pump from Tandem Diabetes Care with Abbott’s Freestyle Libre 2 Plus sensor integration now available in the ...

Acutus Medical has been delisted from the Nasdaq Capital Market, according a recent filing with the U.S. Securities and ...

Field Medical announced today that it began the first-in-human study of its FieldForce pulsed field ablation (PFA) system.

Sapien 3 Ultra Resilia is the only transcatheter aortic valve replacement (TAVR) system incorporating the company’s Resilia ...

R3 Vascular announced today that it closed an $87 million Series B financing round and appointed Christopher Owens as ...

Steris (NYSE: STE), a major provider of sterilization products and services, announced a targeted restructuring to prepare ...

[Image courtesy of Orthofix] Orthofix (Nasdaq: OFIX) + today announced it received FDA 510(k) clearance for its Rodeo ...

Solventum (NYSE: SOLV) today posted first-quarter results that beat the overall consensus on Wall Street. The St. Paul, ...